The Ticagrelor 90mg + Aspirin 75mg COMBIKIT is a dual antiplatelet therapy designed to reduce the risk of cardiovascular events in patients with acute coronary syndrome (ACS) or a history of myocardial infarction. Ticagrelor, a P2Y12 receptor inhibitor, prevents platelet aggregation, while Aspirin, an antiplatelet agent, inhibits thromboxane A2 formation, further reducing clot formation. This COMBIKIT provides a convenient combination of 14 tablets of Ticagrelor 90mg and 7 tablets of Aspirin 75mg, ensuring adherence to prescribed dual antiplatelet therapy for optimal cardiovascular protection.
